Tag: blood and marrow program

BMT Tandem 2015
February 14, 2015/Cancer/Blood Cancers

Patient Socioeconomic Status Impacts Long-Term Outcomes After Allogeneic Hematopoietic Cell Transplant

Study shows lower-income transplant recipients have reduced overall survival

BMT Tandem 2015
February 11, 2015/Cancer/Blood Cancers

Bortezomib-based Induction Therapy Before Transplant Benefits Amyloidosis Patients

Cleveland Clinic study finds regimen helps improve outcomes

majhail-690×380
September 10, 2014/Cancer/Blood Cancers

New Program Name Reflects Blood and Marrow Transplant Progress

Research advances, better treatment protocols improve outcomes

BackPage 1 of 1Next
Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad